Reaction
Cystitis Interstitial reporting signals
As of the last recalculation, Cystitis Interstitial appears in 1,585 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES (PRR 15.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 10 | 15.3 | 15.4 |
| Fesoterodine Fumarate | 12 | 14.6 | 14.7 |
| Sodium Oxybate | 67 | 13.9 | 13.9 |
| Hyoscyamine Sulfate | 9 | 12.9 | 13.0 |
| Lubiprostone | 9 | 12.6 | 12.6 |
| Buspirone Hydrochloride | 10 | 12.0 | 12.0 |
| Armodafinil | 18 | 11.3 | 11.3 |
| Mirabegron | 32 | 11.1 | 11.1 |
| Tizanidine Hydrochloride | 14 | 10.3 | 10.3 |
| Bupivacaine | 7 | 9.9 | 9.9 |
| Vibegron | 6 | 9.9 | 9.9 |
| Nitrofurantoin | 12 | 9.6 | 9.6 |
| Nitrofurantoin (Monohydrate/Macrocrystals) | 12 | 9.5 | 9.5 |
| Esketamine Hydrochloride | 12 | 8.9 | 8.9 |
| Oxybutynin | 19 | 8.6 | 8.6 |
| Vilazodone Hydrochloride | 6 | 8.6 | 8.6 |
| Amikacin | 10 | 7.7 | 7.7 |
| Conjugated Estrogens | 33 | 7.6 | 7.6 |
| Gefitinib | 5 | 7.3 | 7.3 |
| Estrogens, Conjugated | 32 | 7.2 | 7.2 |
| Etonogestrel And Ethinyl Estradiol | 11 | 6.6 | 6.6 |
| Linaclotide | 12 | 5.9 | 5.9 |
| Drospirenone And Ethinyl Estradiol | 18 | 5.4 | 5.4 |
| Tolvaptan | 5 | 4.5 | 4.5 |
| Isotretinoin | 16 | 4.3 | 4.3 |
| Copper | 9 | 2.8 | 2.8 |
| Levonorgestrel | 28 | 1.8 | 1.8 |